News

pharmaphorum2d
After FDA says no, Bayer bags EU nod for twice-yearly Eylea
The European Commission has cleared the high-strength formulation of Eylea (aflibercept) with an extended treatment interval ...
Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
Bristol Myers, Gilead, J&J, Novartis win favorable FDA label updates for cell therapies
Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell ...
Targeted Oncology1d
FDA Approves Updated Labels on 2 CAR T-Cell Therapies
FDA updates CAR T-cell therapy labels for liso-cel and ide-cel, easing monitoring requirements and expanding access for ...
CURE1d
FDA Approves CAR T Therapy Label Updates Across Various Blood Cancers
Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and ...
Healio2d
FDA approves its requested updated warning labels for COVID-19 vaccines
The FDA has approved its requested updated versions of expanded warning labels for COVID-19 vaccines. As Healio previously ...
Contract Pharma2d
FDA Approves REMS Programs in BMS Cell Therapy Labels
Bristol Myers Squibb (BMS) received U.S. Food and Drug Administration (FDA) approval for label updates for its CAR T cell ...